Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04010201
Other study ID # MRCTA,ECFAH of FMU [2019]198
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 25, 2019
Est. completion date December 31, 2079

Study information

Verified date September 2019
Source First Affiliated Hospital of Fujian Medical University
Contact Yi Lin, PhD
Phone 86-0591-87982772
Email linyi7811@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Brain calcification is a common neuroimaging feature in patients with metabolic, neurological, or developmental disorders, infectious diseases, traumatic or toxic history, as well as in otherwise normal older people. To understand the clinical and genetic characteristics of brain calcification, we establish a cohort of brain calcification to follow up patients with brain calcification.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date December 31, 2079
Est. primary completion date December 31, 2029
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with brain calcium deposit(s) based on examinations of CT scans

- Patients with total calcification score(TCS) greater than the physiological threshold

- Relatives of brain calcification patients.

- Unrelated healthy controls

- Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process

Exclusion Criteria:

- Brain calcification caused by specific secondary factors such as infection, poisoning, and trauma

- Participants declining or unable to comply with trial procedures and visit schedule

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Department of Neurology, First Affiliated Hospital Fujian Medical University Fuzhou Fujian

Sponsors (3)

Lead Sponsor Collaborator
Wan-Jin Chen Chang Gung Memorial Hospital, Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of hereditary brain calcification Look for the causative gene in the patient with brian calcification Up to 20 years